The global market for Coronary Bioresorbable Scaffolds was valued at US$ 454 million in the year 2023 and is projected to reach a revised size of US$ 947 million by 2030, growing at a CAGR of 11.1% during the forecast period.

Coronary Bioresorbable Scaffolds Market

Coronary Bioresorbable Scaffolds is a new type of interventional device for coronary heart disease. It is made of biodegradable materials, which can provide temporary mechanical support and drug release to prevent vascular restenosis, and eventually completely degrade in the human body, leaving no permanent implants, so as to restore the natural function and structure of blood vessels.

North American market for Coronary Bioresorbable Scaffolds is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Coronary Bioresorbable Scaffolds is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Coronary Bioresorbable Scaffolds include Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Coronary Bioresorbable Scaffolds, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Bioresorbable Scaffolds.

The Coronary Bioresorbable Scaffolds market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronary Bioresorbable Scaffolds market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Coronary Bioresorbable Scaffolds manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Coronary Bioresorbable Scaffolds Market Report

Report Metric	Details
Report Name	Coronary Bioresorbable Scaffolds Market
Accounted market size in year	US$ 454 million
Forecasted market size in 2030	US$ 947 million
CAGR	11.1%
Base Year	year
Forecasted years	2025 - 2030
by Type	Absorbable Magnesium Scaffolds Polymer Scaffold Polycarbonate Scaffold
by Application	Research and Development Hospital Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, LifeTech Scientific Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coronary Bioresorbable Scaffolds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coronary Bioresorbable Scaffolds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Coronary Bioresorbable Scaffolds Market growing?

Ans: The Coronary Bioresorbable Scaffolds Market witnessing a CAGR of 11.1% during the forecast period 2025-2030.

What is the Coronary Bioresorbable Scaffolds Market size in 2030?

Ans: The Coronary Bioresorbable Scaffolds Market size in 2030 will be US$ 947 million.

Who are the main players in the Coronary Bioresorbable Scaffolds Market report?

Ans: The main players in the Coronary Bioresorbable Scaffolds Market are Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, LifeTech Scientific Corporation

What are the Application segmentation covered in the Coronary Bioresorbable Scaffolds Market report?

Ans: The Applications covered in the Coronary Bioresorbable Scaffolds Market report are Research and Development, Hospital, Others

What are the Type segmentation covered in the Coronary Bioresorbable Scaffolds Market report?

Ans: The Types covered in the Coronary Bioresorbable Scaffolds Market report are Absorbable Magnesium Scaffolds, Polymer Scaffold, Polycarbonate Scaffold

1 Coronary Bioresorbable Scaffolds Market Overview

1.1 Product Definition

1.2 Coronary Bioresorbable Scaffolds by Type

1.2.1 Global Coronary Bioresorbable Scaffolds Market Value Comparison by Type (2024-2030)

1.2.2 Absorbable Magnesium Scaffolds

1.2.3 Polymer Scaffold

1.2.4 Polycarbonate Scaffold

1.3 Coronary Bioresorbable Scaffolds by Application

1.3.1 Global Coronary Bioresorbable Scaffolds Market Value by Application (2024-2030)

1.3.2 Research and Development

1.3.3 Hospital

1.3.4 Others

1.4 Global Coronary Bioresorbable Scaffolds Market Size Estimates and Forecasts

1.4.1 Global Coronary Bioresorbable Scaffolds Revenue 2019-2030

1.4.2 Global Coronary Bioresorbable Scaffolds Sales 2019-2030

1.4.3 Global Coronary Bioresorbable Scaffolds Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Coronary Bioresorbable Scaffolds Market Competition by Manufacturers

2.1 Global Coronary Bioresorbable Scaffolds Sales Market Share by Manufacturers (2019-2024)

2.2 Global Coronary Bioresorbable Scaffolds Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Coronary Bioresorbable Scaffolds Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Coronary Bioresorbable Scaffolds, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Product Type & Application

2.7 Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Date of Enter into This Industry

2.8 Global Coronary Bioresorbable Scaffolds Market Competitive Situation and Trends

2.8.1 Global Coronary Bioresorbable Scaffolds Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Coronary Bioresorbable Scaffolds Players Market Share by Revenue

2.8.3 Global Coronary Bioresorbable Scaffolds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Coronary Bioresorbable Scaffolds Market Scenario by Region

3.1 Global Coronary Bioresorbable Scaffolds Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Coronary Bioresorbable Scaffolds Sales by Region: 2019-2030

3.2.1 Global Coronary Bioresorbable Scaffolds Sales by Region: 2019-2024

3.2.2 Global Coronary Bioresorbable Scaffolds Sales by Region: 2025-2030

3.3 Global Coronary Bioresorbable Scaffolds Revenue by Region: 2019-2030

3.3.1 Global Coronary Bioresorbable Scaffolds Revenue by Region: 2019-2024

3.3.2 Global Coronary Bioresorbable Scaffolds Revenue by Region: 2025-2030

3.4 North America Coronary Bioresorbable Scaffolds Market Facts & Figures by Country

3.4.1 North America Coronary Bioresorbable Scaffolds Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Coronary Bioresorbable Scaffolds Sales by Country (2019-2030)

3.4.3 North America Coronary Bioresorbable Scaffolds Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Coronary Bioresorbable Scaffolds Market Facts & Figures by Country

3.5.1 Europe Coronary Bioresorbable Scaffolds Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Coronary Bioresorbable Scaffolds Sales by Country (2019-2030)

3.5.3 Europe Coronary Bioresorbable Scaffolds Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Coronary Bioresorbable Scaffolds Market Facts & Figures by Region

3.6.1 Asia Pacific Coronary Bioresorbable Scaffolds Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Coronary Bioresorbable Scaffolds Sales by Region (2019-2030)

3.6.3 Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Coronary Bioresorbable Scaffolds Market Facts & Figures by Country

3.7.1 Latin America Coronary Bioresorbable Scaffolds Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Coronary Bioresorbable Scaffolds Sales by Country (2019-2030)

3.7.3 Latin America Coronary Bioresorbable Scaffolds Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Coronary Bioresorbable Scaffolds Market Facts & Figures by Country

3.8.1 Middle East and Africa Coronary Bioresorbable Scaffolds Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Coronary Bioresorbable Scaffolds Sales by Country (2019-2030)

3.8.3 Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Coronary Bioresorbable Scaffolds Sales by Type (2019-2030)

4.1.1 Global Coronary Bioresorbable Scaffolds Sales by Type (2019-2024)

4.1.2 Global Coronary Bioresorbable Scaffolds Sales by Type (2025-2030)

4.1.3 Global Coronary Bioresorbable Scaffolds Sales Market Share by Type (2019-2030)

4.2 Global Coronary Bioresorbable Scaffolds Revenue by Type (2019-2030)

4.2.1 Global Coronary Bioresorbable Scaffolds Revenue by Type (2019-2024)

4.2.2 Global Coronary Bioresorbable Scaffolds Revenue by Type (2025-2030)

4.2.3 Global Coronary Bioresorbable Scaffolds Revenue Market Share by Type (2019-2030)

4.3 Global Coronary Bioresorbable Scaffolds Price by Type (2019-2030)

5 Segment by Application

5.1 Global Coronary Bioresorbable Scaffolds Sales by Application (2019-2030)

5.1.1 Global Coronary Bioresorbable Scaffolds Sales by Application (2019-2024)

5.1.2 Global Coronary Bioresorbable Scaffolds Sales by Application (2025-2030)

5.1.3 Global Coronary Bioresorbable Scaffolds Sales Market Share by Application (2019-2030)

5.2 Global Coronary Bioresorbable Scaffolds Revenue by Application (2019-2030)

5.2.1 Global Coronary Bioresorbable Scaffolds Revenue by Application (2019-2024)

5.2.2 Global Coronary Bioresorbable Scaffolds Revenue by Application (2025-2030)

5.2.3 Global Coronary Bioresorbable Scaffolds Revenue Market Share by Application (2019-2030)

5.3 Global Coronary Bioresorbable Scaffolds Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Company Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Abbott Coronary Bioresorbable Scaffolds Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Company Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Boston Scientific Coronary Bioresorbable Scaffolds Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 Medtronic

6.3.1 Medtronic Company Information

6.3.2 Medtronic Description and Business Overview

6.3.3 Medtronic Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Medtronic Coronary Bioresorbable Scaffolds Product Portfolio

6.3.5 Medtronic Recent Developments/Updates

6.4 Elixir Medical

6.4.1 Elixir Medical Company Information

6.4.2 Elixir Medical Description and Business Overview

6.4.3 Elixir Medical Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Elixir Medical Coronary Bioresorbable Scaffolds Product Portfolio

6.4.5 Elixir Medical Recent Developments/Updates

6.5 Biotronik

6.5.1 Biotronik Company Information

6.5.2 Biotronik Description and Business Overview

6.5.3 Biotronik Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Biotronik Coronary Bioresorbable Scaffolds Product Portfolio

6.5.5 Biotronik Recent Developments/Updates

6.6 B. Braun

6.6.1 B. Braun Company Information

6.6.2 B. Braun Description and Business Overview

6.6.3 B. Braun Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.6.4 B. Braun Coronary Bioresorbable Scaffolds Product Portfolio

6.6.5 B. Braun Recent Developments/Updates

6.7 MicroPort Scientific Corporation

6.7.1 MicroPort Scientific Corporation Company Information

6.7.2 MicroPort Scientific Corporation Description and Business Overview

6.7.3 MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.7.4 MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Product Portfolio

6.7.5 MicroPort Scientific Corporation Recent Developments/Updates

6.8 Terumo Corporation

6.8.1 Terumo Corporation Company Information

6.8.2 Terumo Corporation Description and Business Overview

6.8.3 Terumo Corporation Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Terumo Corporation Coronary Bioresorbable Scaffolds Product Portfolio

6.8.5 Terumo Corporation Recent Developments/Updates

6.9 Lepu Medical Technology (Beijing) Co., Ltd

6.9.1 Lepu Medical Technology (Beijing) Co., Ltd Company Information

6.9.2 Lepu Medical Technology (Beijing) Co., Ltd Description and Business Overview

6.9.3 Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Product Portfolio

6.9.5 Lepu Medical Technology (Beijing) Co., Ltd Recent Developments/Updates

6.10 Hangzhou HuaAn Biotechnology Co., Ltd

6.10.1 Hangzhou HuaAn Biotechnology Co., Ltd Company Information

6.10.2 Hangzhou HuaAn Biotechnology Co., Ltd Description and Business Overview

6.10.3 Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Product Portfolio

6.10.5 Hangzhou HuaAn Biotechnology Co., Ltd Recent Developments/Updates

6.11 LifeTech Scientific Corporation

6.11.1 LifeTech Scientific Corporation Company Information

6.11.2 LifeTech Scientific Corporation Description and Business Overview

6.11.3 LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Sales, Revenue and Gross Margin (2019-2024)

6.11.4 LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Product Portfolio

6.11.5 LifeTech Scientific Corporation Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Coronary Bioresorbable Scaffolds Industry Chain Analysis

7.2 Coronary Bioresorbable Scaffolds Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Coronary Bioresorbable Scaffolds Production Mode & Process

7.4 Coronary Bioresorbable Scaffolds Sales and Marketing

7.4.1 Coronary Bioresorbable Scaffolds Sales Channels

7.4.2 Coronary Bioresorbable Scaffolds Distributors

7.5 Coronary Bioresorbable Scaffolds Customers

8 Coronary Bioresorbable Scaffolds Market Dynamics

8.1 Coronary Bioresorbable Scaffolds Industry Trends

8.2 Coronary Bioresorbable Scaffolds Market Drivers

8.3 Coronary Bioresorbable Scaffolds Market Challenges

8.4 Coronary Bioresorbable Scaffolds Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Microport Scientific Corporation

Terumo Corporation

Lepu Medical Technology(Beijing)Co.,Ltd.

Lifetech Scientific Corporation

Hangzhou HuaAn Biotechnology Co., Ltd

List of Tables

Table 1. Global Coronary Bioresorbable Scaffolds Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Coronary Bioresorbable Scaffolds Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Coronary Bioresorbable Scaffolds Market Competitive Situation by Manufacturers in 2023

Table 4. Global Coronary Bioresorbable Scaffolds Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Coronary Bioresorbable Scaffolds Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Coronary Bioresorbable Scaffolds Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Coronary Bioresorbable Scaffolds Average Price (K US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Coronary Bioresorbable Scaffolds, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Product Type & Application

Table 12. Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Coronary Bioresorbable Scaffolds by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Bioresorbable Scaffolds as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Coronary Bioresorbable Scaffolds Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Coronary Bioresorbable Scaffolds Sales by Region (2019-2024) & (Units)

Table 18. Global Coronary Bioresorbable Scaffolds Sales Market Share by Region (2019-2024)

Table 19. Global Coronary Bioresorbable Scaffolds Sales by Region (2025-2030) & (Units)

Table 20. Global Coronary Bioresorbable Scaffolds Sales Market Share by Region (2025-2030)

Table 21. Global Coronary Bioresorbable Scaffolds Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Region (2019-2024)

Table 23. Global Coronary Bioresorbable Scaffolds Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Region (2025-2030)

Table 25. North America Coronary Bioresorbable Scaffolds Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Coronary Bioresorbable Scaffolds Sales by Country (2019-2024) & (Units)

Table 27. North America Coronary Bioresorbable Scaffolds Sales by Country (2025-2030) & (Units)

Table 28. North America Coronary Bioresorbable Scaffolds Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Coronary Bioresorbable Scaffolds Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Coronary Bioresorbable Scaffolds Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Coronary Bioresorbable Scaffolds Sales by Country (2019-2024) & (Units)

Table 32. Europe Coronary Bioresorbable Scaffolds Sales by Country (2025-2030) & (Units)

Table 33. Europe Coronary Bioresorbable Scaffolds Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Coronary Bioresorbable Scaffolds Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Coronary Bioresorbable Scaffolds Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Coronary Bioresorbable Scaffolds Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Coronary Bioresorbable Scaffolds Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Coronary Bioresorbable Scaffolds Sales by Country (2019-2024) & (Units)

Table 42. Latin America Coronary Bioresorbable Scaffolds Sales by Country (2025-2030) & (Units)

Table 43. Latin America Coronary Bioresorbable Scaffolds Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Coronary Bioresorbable Scaffolds Sales by Country (2019-2024) & (Units)

Table 47. Middle East and Africa Coronary Bioresorbable Scaffolds Sales by Country (2025-2030) & (Units)

Table 48. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Coronary Bioresorbable Scaffolds Sales (Units) by Type (2019-2024)

Table 51. Global Coronary Bioresorbable Scaffolds Sales (Units) by Type (2025-2030)

Table 52. Global Coronary Bioresorbable Scaffolds Sales Market Share by Type (2019-2024)

Table 53. Global Coronary Bioresorbable Scaffolds Sales Market Share by Type (2025-2030)

Table 54. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Type (2019-2024)

Table 57. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Type (2025-2030)

Table 58. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Type (2019-2024)

Table 59. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Type (2025-2030)

Table 60. Global Coronary Bioresorbable Scaffolds Sales (Units) by Application (2019-2024)

Table 61. Global Coronary Bioresorbable Scaffolds Sales (Units) by Application (2025-2030)

Table 62. Global Coronary Bioresorbable Scaffolds Sales Market Share by Application (2019-2024)

Table 63. Global Coronary Bioresorbable Scaffolds Sales Market Share by Application (2025-2030)

Table 64. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Application (2019-2024)

Table 67. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Application (2025-2030)

Table 68. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Application (2019-2024)

Table 69. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Application (2025-2030)

Table 70. Abbott Company Information

Table 71. Abbott Description and Business Overview

Table 72. Abbott Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 73. Abbott Coronary Bioresorbable Scaffolds Product

Table 74. Abbott Recent Developments/Updates

Table 75. Boston Scientific Company Information

Table 76. Boston Scientific Description and Business Overview

Table 77. Boston Scientific Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 78. Boston Scientific Coronary Bioresorbable Scaffolds Product

Table 79. Boston Scientific Recent Developments/Updates

Table 80. Medtronic Company Information

Table 81. Medtronic Description and Business Overview

Table 82. Medtronic Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 83. Medtronic Coronary Bioresorbable Scaffolds Product

Table 84. Medtronic Recent Developments/Updates

Table 85. Elixir Medical Company Information

Table 86. Elixir Medical Description and Business Overview

Table 87. Elixir Medical Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 88. Elixir Medical Coronary Bioresorbable Scaffolds Product

Table 89. Elixir Medical Recent Developments/Updates

Table 90. Biotronik Company Information

Table 91. Biotronik Description and Business Overview

Table 92. Biotronik Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 93. Biotronik Coronary Bioresorbable Scaffolds Product

Table 94. Biotronik Recent Developments/Updates

Table 95. B. Braun Company Information

Table 96. B. Braun Description and Business Overview

Table 97. B. Braun Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 98. B. Braun Coronary Bioresorbable Scaffolds Product

Table 99. B. Braun Recent Developments/Updates

Table 100. MicroPort Scientific Corporation Company Information

Table 101. MicroPort Scientific Corporation Description and Business Overview

Table 102. MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 103. MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Product

Table 104. MicroPort Scientific Corporation Recent Developments/Updates

Table 105. Terumo Corporation Company Information

Table 106. Terumo Corporation Description and Business Overview

Table 107. Terumo Corporation Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 108. Terumo Corporation Coronary Bioresorbable Scaffolds Product

Table 109. Terumo Corporation Recent Developments/Updates

Table 110. Lepu Medical Technology (Beijing) Co., Ltd Company Information

Table 111. Lepu Medical Technology (Beijing) Co., Ltd Description and Business Overview

Table 112. Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 113. Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Product

Table 114. Lepu Medical Technology (Beijing) Co., Ltd Recent Developments/Updates

Table 115. Hangzhou HuaAn Biotechnology Co., Ltd Company Information

Table 116. Hangzhou HuaAn Biotechnology Co., Ltd Description and Business Overview

Table 117. Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 118. Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Product

Table 119. Hangzhou HuaAn Biotechnology Co., Ltd Recent Developments/Updates

Table 120. LifeTech Scientific Corporation Company Information

Table 121. LifeTech Scientific Corporation Description and Business Overview

Table 122. LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2019-2024)

Table 123. LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Product

Table 124. LifeTech Scientific Corporation Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Coronary Bioresorbable Scaffolds Distributors List

Table 128. Coronary Bioresorbable Scaffolds Customers List

Table 129. Coronary Bioresorbable Scaffolds Market Trends

Table 130. Coronary Bioresorbable Scaffolds Market Drivers

Table 131. Coronary Bioresorbable Scaffolds Market Challenges

Table 132. Coronary Bioresorbable Scaffolds Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Coronary Bioresorbable Scaffolds

Figure 2. Global Coronary Bioresorbable Scaffolds Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Coronary Bioresorbable Scaffolds Market Share by Type: 2023 & 2030

Figure 4. Absorbable Magnesium Scaffolds Product Picture

Figure 5. Polymer Scaffold Product Picture

Figure 6. Polycarbonate Scaffold Product Picture

Figure 7. Global Coronary Bioresorbable Scaffolds Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Coronary Bioresorbable Scaffolds Market Share by Application: 2023 & 2030

Figure 9. Research and Development

Figure 10. Hospital

Figure 11. Others

Figure 12. Global Coronary Bioresorbable Scaffolds Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Coronary Bioresorbable Scaffolds Market Size (2019-2030) & (US$ Million)

Figure 14. Global Coronary Bioresorbable Scaffolds Sales (2019-2030) & (Units)

Figure 15. Global Coronary Bioresorbable Scaffolds Average Price (K US$/Unit) & (2019-2030)

Figure 16. Coronary Bioresorbable Scaffolds Report Years Considered

Figure 17. Coronary Bioresorbable Scaffolds Sales Share by Manufacturers in 2023

Figure 18. Global Coronary Bioresorbable Scaffolds Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Coronary Bioresorbable Scaffolds Players: Market Share by Revenue in Coronary Bioresorbable Scaffolds in 2023

Figure 20. Coronary Bioresorbable Scaffolds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Coronary Bioresorbable Scaffolds Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Coronary Bioresorbable Scaffolds Sales Market Share by Country (2019-2030)

Figure 23. North America Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2019-2030)

Figure 24. United States Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Coronary Bioresorbable Scaffolds Sales Market Share by Country (2019-2030)

Figure 27. Europe Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2019-2030)

Figure 28. Germany Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Coronary Bioresorbable Scaffolds Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Coronary Bioresorbable Scaffolds Revenue Market Share by Region (2019-2030)

Figure 35. China Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Coronary Bioresorbable Scaffolds Sales Market Share by Country (2019-2030)

Figure 43. Mexico Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Coronary Bioresorbable Scaffolds Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Coronary Bioresorbable Scaffolds Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Coronary Bioresorbable Scaffolds by Type (2019-2030)

Figure 53. Global Revenue Market Share of Coronary Bioresorbable Scaffolds by Type (2019-2030)

Figure 54. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Coronary Bioresorbable Scaffolds by Application (2019-2030)

Figure 56. Global Revenue Market Share of Coronary Bioresorbable Scaffolds by Application (2019-2030)

Figure 57. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Application (2019-2030)

Figure 58. Coronary Bioresorbable Scaffolds Value Chain

Figure 59. Coronary Bioresorbable Scaffolds Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Small Bone and Joint Devices Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-20W9910

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Vaporized Hydrogen Peroxide Sterilizers for Medical Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12H9516

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Somatic Cell Analyzers Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-30I3483

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Dental CAM Cutting Machine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3M18891

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions